It’s amazing to see the advancements in the field of biotechnology! Organogenesis Inc. is a world leading company specializing in bio-active chronic wounds healing, oral regeneration and bio-surgery. They have marketed a product called Apligraf; FDA-approved to treat two types of chronic wounds—venous leg ulcers and diabetic foot ulcers.
Apligraf is made up of, “a matrix of cow collagen, human fibroblasts and keratinocyte stem cells (from discarded circumcisions)." The bilayered skin substitute is applied to chronic wounds; such as diabetic foot ulcers, venous leg ulcers and pressure ulcers.
In the clinical trials, Apligraf healed diabetic foot ulcers 100% in twelve weeks! That is good news to the 600,000-800,000 diabetics in the United States, who suffer from foot ulcers.
4,562 clicks in 212 w
More Stats +/-